Smith, R
Diabetologia 65(8):12511261
The research leading to these results has received funding from AIRC and Fondazione CR Firenze (IG 2018 - ID
By taking a GLP-1 receptor agonist, people are able to supplement natural levels of GLP-1, promoting its effects within the body
Physical activity, dietary changes, and other microbiota-targeted intervention strategies discussed in this review are extremely beneficial in CKD management as they offer a non-invasive approach to the reduction of uremic toxins, enhancement of the intestinal barrier integrity and that of the BBB, lowering inflammation and oxidative stress, SCFAs generation, modulation of neurotransmitter levels, and immune responses that ultimately slow kidney function decline, decreasing the occurrence of associated complications, and greatly improving the quality of lives of affected individuals
Researchers studying peptide signaling often examine this compound when analyzing peptide structure and peptide interactions within laboratory environments